BRCA2 and breast carcinoma: The variable that most strongly predicted mortality in women with BRCA2-associated breast cancer was positive ER status; in the multivariate analysis, women with ER-positive tumours were more likely to die than women with ER-negative tumours (HR 2.08, 95% CI 0.99–4.36, p = 0.05).